Multidisciplinary Lipid Management for Prevention of Cardiovascular Risks

The value of interdisciplinary research and multidisciplinary care of patients at high risk for cardiovascular events.

The standard of care for managing high cholesterol levels.

Recommendations for establishing relationships and talking with patients about primary and secondary prevention against cardiovascular events.

Criteria and types of health care professionals who may screen patients at high risk for cardiovascular disease.

Approaches to counseling patients with high cholesterol levels on goals of therapy and the role of lifestyle changes as prevention against cardiovascular events.

What to know about the efficacy of statin therapies used as cholesterol-lowering therapy.

The role of ezetimibe and PCSK9 inhibitors as treatment for patients who are statin intolerant or require add-on therapy to help reduce cholesterol levels.

Opportunities to reduce costs and improve accessibility to therapies used for hypercholesterolemia and prophylaxis against cardiovascular events.

An overview of the REDUCE-IT trial of icosapent ethyl for the management of triglycerides and prevention of cardiovascular events.

Takeaways of the REDUCE-IT trial of icosapent ethyl as treatment for dyslipidemia and hypertriglyceridemia.

What pharmacists and providers need to know to counsel patients on when discussing the use of prescription or over-the-counter fish oil supplement as treatment for dyslipidemia and hypertriglyceridemia.

An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.